Review



rbx2 polyclonal antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Proteintech rbx2 polyclonal antibody
    (A) Ablation of RBX1 diminishes amino acid-induced mTORC1 activation in EMSCs. Three gRNAs designed to target distinct exon regions of RBX1 were used. Cells were starved in amino acid-deprived medium for 50 min and treated with 1× amino acids for 10 min. gRNA targeting GFP was used as a control. Note that RBX1–3 gRNA failed to ablate RBX1. (B) Ablation of RBX1, but not <t>RBX2,</t> diminishes amino acid-induced mTORC1 activation in EMSCs. Cells were treated as in (A). Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. * p < 0.05, ** p < 0.01, mean ± SD, n = 4. (C) Ablation of RBX1 diminishes CQ/MG-induced mTORC1 activation in Ragulator-deficient cells. RBX1 is ablated in p18/LAMTOR1 knockout (KO) EMSCs. Cells were treated with CQ (50 μM) or/and MG (20 μM) in amino acid-free medium for 45 min. (D) Ablation of RBX1 diminishes Rheb ubiquitination. RBX1 KO EMSCs were lysed under amino acid-replete conditions in RIPA buffer containing the deubiquitinase inhibitor (100 mM) N-ethylmaleimide (NEM). The lysates were subjected to SDS-PAGE, and levels of Rheb and Ub-Rheb were monitored with a Rheb antibody. Non-Ub-Rheb and Ub-Rheb are indicated. (E) MLN4924 specifically inhibits mTORC1 activity induced by amino acids in EMSCs. Cells were treated with the indicated concentrations of MLN4924 for 16 h. Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. **** p < 0.0001, mean ± SD, n = 4. (F) MLN4924 inhibits mTORC1 activity induced by amino acids in both control and DEPDC5 KO HEK293T cells. Cells were treated with MLN4924 (1 μM) as in (E). Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. The effect of DEPDC5 ablation was confirmed by the high levels of mTORC1 activity resistant to amino acid starvation. (G) MLN4924 diminishes levels of Ub-Rheb in HEK293T cells. Cells were treated with MLN4924 (1 μM) for 16 h and lysed as in (D), and the lysates were subjected to immunoblotting with a Rheb antibody.
    Rbx2 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rbx2+polyclonal+antibody/RNF7+Antibody/pmc11844325-27-0-4
    Average 93 stars, based on 9 article reviews
    rbx2 polyclonal antibody - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation"

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation

    Journal: Cell reports

    doi: 10.1016/j.celrep.2024.115101

    (A) Ablation of RBX1 diminishes amino acid-induced mTORC1 activation in EMSCs. Three gRNAs designed to target distinct exon regions of RBX1 were used. Cells were starved in amino acid-deprived medium for 50 min and treated with 1× amino acids for 10 min. gRNA targeting GFP was used as a control. Note that RBX1–3 gRNA failed to ablate RBX1. (B) Ablation of RBX1, but not RBX2, diminishes amino acid-induced mTORC1 activation in EMSCs. Cells were treated as in (A). Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. * p < 0.05, ** p < 0.01, mean ± SD, n = 4. (C) Ablation of RBX1 diminishes CQ/MG-induced mTORC1 activation in Ragulator-deficient cells. RBX1 is ablated in p18/LAMTOR1 knockout (KO) EMSCs. Cells were treated with CQ (50 μM) or/and MG (20 μM) in amino acid-free medium for 45 min. (D) Ablation of RBX1 diminishes Rheb ubiquitination. RBX1 KO EMSCs were lysed under amino acid-replete conditions in RIPA buffer containing the deubiquitinase inhibitor (100 mM) N-ethylmaleimide (NEM). The lysates were subjected to SDS-PAGE, and levels of Rheb and Ub-Rheb were monitored with a Rheb antibody. Non-Ub-Rheb and Ub-Rheb are indicated. (E) MLN4924 specifically inhibits mTORC1 activity induced by amino acids in EMSCs. Cells were treated with the indicated concentrations of MLN4924 for 16 h. Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. **** p < 0.0001, mean ± SD, n = 4. (F) MLN4924 inhibits mTORC1 activity induced by amino acids in both control and DEPDC5 KO HEK293T cells. Cells were treated with MLN4924 (1 μM) as in (E). Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. The effect of DEPDC5 ablation was confirmed by the high levels of mTORC1 activity resistant to amino acid starvation. (G) MLN4924 diminishes levels of Ub-Rheb in HEK293T cells. Cells were treated with MLN4924 (1 μM) for 16 h and lysed as in (D), and the lysates were subjected to immunoblotting with a Rheb antibody.
    Figure Legend Snippet: (A) Ablation of RBX1 diminishes amino acid-induced mTORC1 activation in EMSCs. Three gRNAs designed to target distinct exon regions of RBX1 were used. Cells were starved in amino acid-deprived medium for 50 min and treated with 1× amino acids for 10 min. gRNA targeting GFP was used as a control. Note that RBX1–3 gRNA failed to ablate RBX1. (B) Ablation of RBX1, but not RBX2, diminishes amino acid-induced mTORC1 activation in EMSCs. Cells were treated as in (A). Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. * p < 0.05, ** p < 0.01, mean ± SD, n = 4. (C) Ablation of RBX1 diminishes CQ/MG-induced mTORC1 activation in Ragulator-deficient cells. RBX1 is ablated in p18/LAMTOR1 knockout (KO) EMSCs. Cells were treated with CQ (50 μM) or/and MG (20 μM) in amino acid-free medium for 45 min. (D) Ablation of RBX1 diminishes Rheb ubiquitination. RBX1 KO EMSCs were lysed under amino acid-replete conditions in RIPA buffer containing the deubiquitinase inhibitor (100 mM) N-ethylmaleimide (NEM). The lysates were subjected to SDS-PAGE, and levels of Rheb and Ub-Rheb were monitored with a Rheb antibody. Non-Ub-Rheb and Ub-Rheb are indicated. (E) MLN4924 specifically inhibits mTORC1 activity induced by amino acids in EMSCs. Cells were treated with the indicated concentrations of MLN4924 for 16 h. Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. **** p < 0.0001, mean ± SD, n = 4. (F) MLN4924 inhibits mTORC1 activity induced by amino acids in both control and DEPDC5 KO HEK293T cells. Cells were treated with MLN4924 (1 μM) as in (E). Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. The effect of DEPDC5 ablation was confirmed by the high levels of mTORC1 activity resistant to amino acid starvation. (G) MLN4924 diminishes levels of Ub-Rheb in HEK293T cells. Cells were treated with MLN4924 (1 μM) for 16 h and lysed as in (D), and the lysates were subjected to immunoblotting with a Rheb antibody.

    Techniques Used: Activation Assay, Control, Knock-Out, Ubiquitin Proteomics, SDS Page, Activity Assay, Western Blot


    Figure Legend Snippet:

    Techniques Used: Virus, Recombinant, Magnetic Beads, Control, Negative Control, Ubiquitin Proteomics, shRNA, Plasmid Preparation, Immunofluorescence, Software

    Related Articles

    Activation Assay:

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation
    Article Snippet: Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.. RBX2 polyclonal antibody , Proteintech , Cat 11905-1-AP; RRID:AB_10697836.. Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.

    Control:

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation
    Article Snippet: Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.. RBX2 polyclonal antibody , Proteintech , Cat 11905-1-AP; RRID:AB_10697836.. Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.

    Knock-Out:

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation
    Article Snippet: Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.. RBX2 polyclonal antibody , Proteintech , Cat 11905-1-AP; RRID:AB_10697836.. Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.

    Ubiquitin Proteomics:

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation
    Article Snippet: Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.. RBX2 polyclonal antibody , Proteintech , Cat 11905-1-AP; RRID:AB_10697836.. Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.

    SDS Page:

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation
    Article Snippet: Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.. RBX2 polyclonal antibody , Proteintech , Cat 11905-1-AP; RRID:AB_10697836.. Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.

    Activity Assay:

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation
    Article Snippet: Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.. RBX2 polyclonal antibody , Proteintech , Cat 11905-1-AP; RRID:AB_10697836.. Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.

    Western Blot:

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation
    Article Snippet: Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.. RBX2 polyclonal antibody , Proteintech , Cat 11905-1-AP; RRID:AB_10697836.. Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.

    Virus:

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation
    Article Snippet: Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.. RBX2 polyclonal antibody , Proteintech , Cat 11905-1-AP; RRID:AB_10697836.. Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.

    Recombinant:

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation
    Article Snippet: Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.. RBX2 polyclonal antibody , Proteintech , Cat 11905-1-AP; RRID:AB_10697836.. Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.

    Magnetic Beads:

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation
    Article Snippet: Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.. RBX2 polyclonal antibody , Proteintech , Cat 11905-1-AP; RRID:AB_10697836.. Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.

    Negative Control:

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation
    Article Snippet: Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.. RBX2 polyclonal antibody , Proteintech , Cat 11905-1-AP; RRID:AB_10697836.. Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.

    shRNA:

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation
    Article Snippet: Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.. RBX2 polyclonal antibody , Proteintech , Cat 11905-1-AP; RRID:AB_10697836.. Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.

    Plasmid Preparation:

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation
    Article Snippet: Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.. RBX2 polyclonal antibody , Proteintech , Cat 11905-1-AP; RRID:AB_10697836.. Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.

    Immunofluorescence:

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation
    Article Snippet: Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.. RBX2 polyclonal antibody , Proteintech , Cat 11905-1-AP; RRID:AB_10697836.. Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.

    Software:

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation
    Article Snippet: Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.Rabbit polyclonal anti-KLHL22 , Proteintech , Cat# 16214-1-AP; RRID:AB_2131201.. RBX2 polyclonal antibody , Proteintech , Cat 11905-1-AP; RRID:AB_10697836.. Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.Mouse monoclonal anti-Rheb (clone 2C11) (for WB) , Novus Biologicals , Cat#H00006009-M01; RRID:AB_1112097.



    Similar Products

    93
    Proteintech rbx2 polyclonal antibody
    (A) Ablation of RBX1 diminishes amino acid-induced mTORC1 activation in EMSCs. Three gRNAs designed to target distinct exon regions of RBX1 were used. Cells were starved in amino acid-deprived medium for 50 min and treated with 1× amino acids for 10 min. gRNA targeting GFP was used as a control. Note that RBX1–3 gRNA failed to ablate RBX1. (B) Ablation of RBX1, but not <t>RBX2,</t> diminishes amino acid-induced mTORC1 activation in EMSCs. Cells were treated as in (A). Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. * p < 0.05, ** p < 0.01, mean ± SD, n = 4. (C) Ablation of RBX1 diminishes CQ/MG-induced mTORC1 activation in Ragulator-deficient cells. RBX1 is ablated in p18/LAMTOR1 knockout (KO) EMSCs. Cells were treated with CQ (50 μM) or/and MG (20 μM) in amino acid-free medium for 45 min. (D) Ablation of RBX1 diminishes Rheb ubiquitination. RBX1 KO EMSCs were lysed under amino acid-replete conditions in RIPA buffer containing the deubiquitinase inhibitor (100 mM) N-ethylmaleimide (NEM). The lysates were subjected to SDS-PAGE, and levels of Rheb and Ub-Rheb were monitored with a Rheb antibody. Non-Ub-Rheb and Ub-Rheb are indicated. (E) MLN4924 specifically inhibits mTORC1 activity induced by amino acids in EMSCs. Cells were treated with the indicated concentrations of MLN4924 for 16 h. Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. **** p < 0.0001, mean ± SD, n = 4. (F) MLN4924 inhibits mTORC1 activity induced by amino acids in both control and DEPDC5 KO HEK293T cells. Cells were treated with MLN4924 (1 μM) as in (E). Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. The effect of DEPDC5 ablation was confirmed by the high levels of mTORC1 activity resistant to amino acid starvation. (G) MLN4924 diminishes levels of Ub-Rheb in HEK293T cells. Cells were treated with MLN4924 (1 μM) for 16 h and lysed as in (D), and the lysates were subjected to immunoblotting with a Rheb antibody.
    Rbx2 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rbx2+polyclonal+antibody/RNF7+Antibody/pmc11844325-27-0-4
    Average 93 stars, based on 1 article reviews
    rbx2 polyclonal antibody - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology anti-rbx2 (n-15) goat polyclonal antibodies
    (A) Ablation of RBX1 diminishes amino acid-induced mTORC1 activation in EMSCs. Three gRNAs designed to target distinct exon regions of RBX1 were used. Cells were starved in amino acid-deprived medium for 50 min and treated with 1× amino acids for 10 min. gRNA targeting GFP was used as a control. Note that RBX1–3 gRNA failed to ablate RBX1. (B) Ablation of RBX1, but not <t>RBX2,</t> diminishes amino acid-induced mTORC1 activation in EMSCs. Cells were treated as in (A). Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. * p < 0.05, ** p < 0.01, mean ± SD, n = 4. (C) Ablation of RBX1 diminishes CQ/MG-induced mTORC1 activation in Ragulator-deficient cells. RBX1 is ablated in p18/LAMTOR1 knockout (KO) EMSCs. Cells were treated with CQ (50 μM) or/and MG (20 μM) in amino acid-free medium for 45 min. (D) Ablation of RBX1 diminishes Rheb ubiquitination. RBX1 KO EMSCs were lysed under amino acid-replete conditions in RIPA buffer containing the deubiquitinase inhibitor (100 mM) N-ethylmaleimide (NEM). The lysates were subjected to SDS-PAGE, and levels of Rheb and Ub-Rheb were monitored with a Rheb antibody. Non-Ub-Rheb and Ub-Rheb are indicated. (E) MLN4924 specifically inhibits mTORC1 activity induced by amino acids in EMSCs. Cells were treated with the indicated concentrations of MLN4924 for 16 h. Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. **** p < 0.0001, mean ± SD, n = 4. (F) MLN4924 inhibits mTORC1 activity induced by amino acids in both control and DEPDC5 KO HEK293T cells. Cells were treated with MLN4924 (1 μM) as in (E). Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. The effect of DEPDC5 ablation was confirmed by the high levels of mTORC1 activity resistant to amino acid starvation. (G) MLN4924 diminishes levels of Ub-Rheb in HEK293T cells. Cells were treated with MLN4924 (1 μM) for 16 h and lysed as in (D), and the lysates were subjected to immunoblotting with a Rheb antibody.
    Anti Rbx2 (N 15) Goat Polyclonal Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rbx2+polyclonal+antibody/anti+rbx1/pmc02712087-128-3-20
    Average 90 stars, based on 1 article reviews
    anti-rbx2 (n-15) goat polyclonal antibodies - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology anti rbx2 n 15 goat polyclonal antibodies
    (A) Ablation of RBX1 diminishes amino acid-induced mTORC1 activation in EMSCs. Three gRNAs designed to target distinct exon regions of RBX1 were used. Cells were starved in amino acid-deprived medium for 50 min and treated with 1× amino acids for 10 min. gRNA targeting GFP was used as a control. Note that RBX1–3 gRNA failed to ablate RBX1. (B) Ablation of RBX1, but not <t>RBX2,</t> diminishes amino acid-induced mTORC1 activation in EMSCs. Cells were treated as in (A). Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. * p < 0.05, ** p < 0.01, mean ± SD, n = 4. (C) Ablation of RBX1 diminishes CQ/MG-induced mTORC1 activation in Ragulator-deficient cells. RBX1 is ablated in p18/LAMTOR1 knockout (KO) EMSCs. Cells were treated with CQ (50 μM) or/and MG (20 μM) in amino acid-free medium for 45 min. (D) Ablation of RBX1 diminishes Rheb ubiquitination. RBX1 KO EMSCs were lysed under amino acid-replete conditions in RIPA buffer containing the deubiquitinase inhibitor (100 mM) N-ethylmaleimide (NEM). The lysates were subjected to SDS-PAGE, and levels of Rheb and Ub-Rheb were monitored with a Rheb antibody. Non-Ub-Rheb and Ub-Rheb are indicated. (E) MLN4924 specifically inhibits mTORC1 activity induced by amino acids in EMSCs. Cells were treated with the indicated concentrations of MLN4924 for 16 h. Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. **** p < 0.0001, mean ± SD, n = 4. (F) MLN4924 inhibits mTORC1 activity induced by amino acids in both control and DEPDC5 KO HEK293T cells. Cells were treated with MLN4924 (1 μM) as in (E). Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. The effect of DEPDC5 ablation was confirmed by the high levels of mTORC1 activity resistant to amino acid starvation. (G) MLN4924 diminishes levels of Ub-Rheb in HEK293T cells. Cells were treated with MLN4924 (1 μM) for 16 h and lysed as in (D), and the lysates were subjected to immunoblotting with a Rheb antibody.
    Anti Rbx2 N 15 Goat Polyclonal Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rbx2+polyclonal+antibody/normal+mouse+IgG2a/pmc02712087-128-8-20
    Average 94 stars, based on 1 article reviews
    anti rbx2 n 15 goat polyclonal antibodies - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology goat polyclonal antibody to rbx2 n 15
    (A) Ablation of RBX1 diminishes amino acid-induced mTORC1 activation in EMSCs. Three gRNAs designed to target distinct exon regions of RBX1 were used. Cells were starved in amino acid-deprived medium for 50 min and treated with 1× amino acids for 10 min. gRNA targeting GFP was used as a control. Note that RBX1–3 gRNA failed to ablate RBX1. (B) Ablation of RBX1, but not <t>RBX2,</t> diminishes amino acid-induced mTORC1 activation in EMSCs. Cells were treated as in (A). Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. * p < 0.05, ** p < 0.01, mean ± SD, n = 4. (C) Ablation of RBX1 diminishes CQ/MG-induced mTORC1 activation in Ragulator-deficient cells. RBX1 is ablated in p18/LAMTOR1 knockout (KO) EMSCs. Cells were treated with CQ (50 μM) or/and MG (20 μM) in amino acid-free medium for 45 min. (D) Ablation of RBX1 diminishes Rheb ubiquitination. RBX1 KO EMSCs were lysed under amino acid-replete conditions in RIPA buffer containing the deubiquitinase inhibitor (100 mM) N-ethylmaleimide (NEM). The lysates were subjected to SDS-PAGE, and levels of Rheb and Ub-Rheb were monitored with a Rheb antibody. Non-Ub-Rheb and Ub-Rheb are indicated. (E) MLN4924 specifically inhibits mTORC1 activity induced by amino acids in EMSCs. Cells were treated with the indicated concentrations of MLN4924 for 16 h. Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. **** p < 0.0001, mean ± SD, n = 4. (F) MLN4924 inhibits mTORC1 activity induced by amino acids in both control and DEPDC5 KO HEK293T cells. Cells were treated with MLN4924 (1 μM) as in (E). Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. The effect of DEPDC5 ablation was confirmed by the high levels of mTORC1 activity resistant to amino acid starvation. (G) MLN4924 diminishes levels of Ub-Rheb in HEK293T cells. Cells were treated with MLN4924 (1 μM) for 16 h and lysed as in (D), and the lysates were subjected to immunoblotting with a Rheb antibody.
    Goat Polyclonal Antibody To Rbx2 N 15, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rbx2+polyclonal+antibody/Rbx2+Antibody/pm16325183-41-26-33
    Average 93 stars, based on 1 article reviews
    goat polyclonal antibody to rbx2 n 15 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology goat polyclonal antibodies to rbx2
    (A) Ablation of RBX1 diminishes amino acid-induced mTORC1 activation in EMSCs. Three gRNAs designed to target distinct exon regions of RBX1 were used. Cells were starved in amino acid-deprived medium for 50 min and treated with 1× amino acids for 10 min. gRNA targeting GFP was used as a control. Note that RBX1–3 gRNA failed to ablate RBX1. (B) Ablation of RBX1, but not <t>RBX2,</t> diminishes amino acid-induced mTORC1 activation in EMSCs. Cells were treated as in (A). Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. * p < 0.05, ** p < 0.01, mean ± SD, n = 4. (C) Ablation of RBX1 diminishes CQ/MG-induced mTORC1 activation in Ragulator-deficient cells. RBX1 is ablated in p18/LAMTOR1 knockout (KO) EMSCs. Cells were treated with CQ (50 μM) or/and MG (20 μM) in amino acid-free medium for 45 min. (D) Ablation of RBX1 diminishes Rheb ubiquitination. RBX1 KO EMSCs were lysed under amino acid-replete conditions in RIPA buffer containing the deubiquitinase inhibitor (100 mM) N-ethylmaleimide (NEM). The lysates were subjected to SDS-PAGE, and levels of Rheb and Ub-Rheb were monitored with a Rheb antibody. Non-Ub-Rheb and Ub-Rheb are indicated. (E) MLN4924 specifically inhibits mTORC1 activity induced by amino acids in EMSCs. Cells were treated with the indicated concentrations of MLN4924 for 16 h. Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. **** p < 0.0001, mean ± SD, n = 4. (F) MLN4924 inhibits mTORC1 activity induced by amino acids in both control and DEPDC5 KO HEK293T cells. Cells were treated with MLN4924 (1 μM) as in (E). Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. The effect of DEPDC5 ablation was confirmed by the high levels of mTORC1 activity resistant to amino acid starvation. (G) MLN4924 diminishes levels of Ub-Rheb in HEK293T cells. Cells were treated with MLN4924 (1 μM) for 16 h and lysed as in (D), and the lysates were subjected to immunoblotting with a Rheb antibody.
    Goat Polyclonal Antibodies To Rbx2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rbx2+polyclonal+antibody/Rbx2+Antibody/pmc00535916-297-17-29
    Average 93 stars, based on 1 article reviews
    goat polyclonal antibodies to rbx2 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    (A) Ablation of RBX1 diminishes amino acid-induced mTORC1 activation in EMSCs. Three gRNAs designed to target distinct exon regions of RBX1 were used. Cells were starved in amino acid-deprived medium for 50 min and treated with 1× amino acids for 10 min. gRNA targeting GFP was used as a control. Note that RBX1–3 gRNA failed to ablate RBX1. (B) Ablation of RBX1, but not RBX2, diminishes amino acid-induced mTORC1 activation in EMSCs. Cells were treated as in (A). Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. * p < 0.05, ** p < 0.01, mean ± SD, n = 4. (C) Ablation of RBX1 diminishes CQ/MG-induced mTORC1 activation in Ragulator-deficient cells. RBX1 is ablated in p18/LAMTOR1 knockout (KO) EMSCs. Cells were treated with CQ (50 μM) or/and MG (20 μM) in amino acid-free medium for 45 min. (D) Ablation of RBX1 diminishes Rheb ubiquitination. RBX1 KO EMSCs were lysed under amino acid-replete conditions in RIPA buffer containing the deubiquitinase inhibitor (100 mM) N-ethylmaleimide (NEM). The lysates were subjected to SDS-PAGE, and levels of Rheb and Ub-Rheb were monitored with a Rheb antibody. Non-Ub-Rheb and Ub-Rheb are indicated. (E) MLN4924 specifically inhibits mTORC1 activity induced by amino acids in EMSCs. Cells were treated with the indicated concentrations of MLN4924 for 16 h. Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. **** p < 0.0001, mean ± SD, n = 4. (F) MLN4924 inhibits mTORC1 activity induced by amino acids in both control and DEPDC5 KO HEK293T cells. Cells were treated with MLN4924 (1 μM) as in (E). Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. The effect of DEPDC5 ablation was confirmed by the high levels of mTORC1 activity resistant to amino acid starvation. (G) MLN4924 diminishes levels of Ub-Rheb in HEK293T cells. Cells were treated with MLN4924 (1 μM) for 16 h and lysed as in (D), and the lysates were subjected to immunoblotting with a Rheb antibody.

    Journal: Cell reports

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation

    doi: 10.1016/j.celrep.2024.115101

    Figure Lengend Snippet: (A) Ablation of RBX1 diminishes amino acid-induced mTORC1 activation in EMSCs. Three gRNAs designed to target distinct exon regions of RBX1 were used. Cells were starved in amino acid-deprived medium for 50 min and treated with 1× amino acids for 10 min. gRNA targeting GFP was used as a control. Note that RBX1–3 gRNA failed to ablate RBX1. (B) Ablation of RBX1, but not RBX2, diminishes amino acid-induced mTORC1 activation in EMSCs. Cells were treated as in (A). Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. * p < 0.05, ** p < 0.01, mean ± SD, n = 4. (C) Ablation of RBX1 diminishes CQ/MG-induced mTORC1 activation in Ragulator-deficient cells. RBX1 is ablated in p18/LAMTOR1 knockout (KO) EMSCs. Cells were treated with CQ (50 μM) or/and MG (20 μM) in amino acid-free medium for 45 min. (D) Ablation of RBX1 diminishes Rheb ubiquitination. RBX1 KO EMSCs were lysed under amino acid-replete conditions in RIPA buffer containing the deubiquitinase inhibitor (100 mM) N-ethylmaleimide (NEM). The lysates were subjected to SDS-PAGE, and levels of Rheb and Ub-Rheb were monitored with a Rheb antibody. Non-Ub-Rheb and Ub-Rheb are indicated. (E) MLN4924 specifically inhibits mTORC1 activity induced by amino acids in EMSCs. Cells were treated with the indicated concentrations of MLN4924 for 16 h. Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. Levels of phosphorylated S6K1 in the indicated cells (amino acid-replete conditions) were quantified and expressed as the ratio of pS6K/S6K1. **** p < 0.0001, mean ± SD, n = 4. (F) MLN4924 inhibits mTORC1 activity induced by amino acids in both control and DEPDC5 KO HEK293T cells. Cells were treated with MLN4924 (1 μM) as in (E). Cells were amino acid starved for 50 min and re-stimulated with 1× amino acids for 10 min. The effect of DEPDC5 ablation was confirmed by the high levels of mTORC1 activity resistant to amino acid starvation. (G) MLN4924 diminishes levels of Ub-Rheb in HEK293T cells. Cells were treated with MLN4924 (1 μM) for 16 h and lysed as in (D), and the lysates were subjected to immunoblotting with a Rheb antibody.

    Article Snippet: RBX2 polyclonal antibody , Proteintech , Cat# 11905-1-AP; RRID:AB_10697836.

    Techniques: Activation Assay, Control, Knock-Out, Ubiquitin Proteomics, SDS Page, Activity Assay, Western Blot

    Journal: Cell reports

    Article Title: The Cullin3-Rbx1-KLHL9 E3 ubiquitin ligase complex ubiquitinates Rheb and supports amino acid-induced mTORC1 activation

    doi: 10.1016/j.celrep.2024.115101

    Figure Lengend Snippet:

    Article Snippet: RBX2 polyclonal antibody , Proteintech , Cat# 11905-1-AP; RRID:AB_10697836.

    Techniques: Virus, Recombinant, Magnetic Beads, Control, Negative Control, Ubiquitin Proteomics, shRNA, Plasmid Preparation, Immunofluorescence, Software